Michael Greiner - Avanos Medical Chief Financial Officer, Senior Vice President

Michael Greiner Latest Insider Activity

Avanos Medical Management Efficiency

The company has return on total asset (ROA) of 0.0208 % which means that it generated a profit of $0.0208 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0177 %, meaning that it created $0.0177 on every $100 dollars invested by stockholders. Avanos Medical's management efficiency ratios could be used to measure how well Avanos Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to gain to 0 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (0.09). At this time, Avanos Medical's Total Current Assets are comparatively stable compared to the past year. Intangibles To Total Assets is likely to gain to 0.63 in 2024, whereas Net Tangible Assets are likely to drop slightly above 181.9 M in 2024.

Similar Executives

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia. Avanos Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 4555 people. Avanos Medical (AVNS) is traded on New York Stock Exchange in USA. It is located in 5405 Windward Parkway, Alpharetta, GA, United States, 30004 and employs 3,771 people. Avanos Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Avanos Medical Leadership Team

Avanos Stock Performance Indicators

Additional Tools for Avanos Stock Analysis